Spheroidal mesenchymal stem cells therapy(Acibadem University)

球形间充质干细胞疗法（Acibadem University）

Report date: 2023/02/07 20:00:24

Base Information

Drug NameSpheroidal mesenchymal stem cells therapy(Acibadem University)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsRetinitis PigmentosaHematopoietic stem cell transplantation (HSCT)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTurkey

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAcibadem University

China Registration ClassN/A

Develop Information

Active CompaniesAcibadem University

Inactive CompaniesN/A

Active IndicationsRetinitis PigmentosaHematopoietic stem cell transplantation (HSCT)

Inactive IndicationsN/A

Other Information

ATC CodeN/A